Vertaling van "laboratories " (Nederlands → Frans) :

On the other hand, it is advised that the laboratory keep a set of MRSA isolates (minimum 10) from different patients and send it to a reference laboratory for epidemiological typing (genotyping by pulsed-field gel electrophoresis and additional methods as appropriate).
D'autre part, on conseille que le laboratoire garde une série d’isolats de MRSA (au minimum 10) de différents patients et l'envoie à un laboratoire de référence pour le typage épidémiologique (génotypage par électrophorèse de gel à champ pulsé et d’autres méthodes additionnelles si celles-ci s’avèrent utiles).

het Zoötechnisch Centrum (R&D / Laboratory Quality Care in Animal Production) van KULeuven (www.biw.kuleuven.be)
le Centre zootechnique (K.U.Leuven R&D / Laboratory Quality Care in Animal Production) de l'Université catholique de Louvain (www.biw.kuleuven.be)

Gembloux Agriculural University - GLP Pesticide Science Laboratory (www.fsagx.ac.be)
le GLP Pesticide Science Laboratory de la Faculté universitaire des Sciences Agronomiques de Gembloux (www.fsagx.ac.be)

Gembloux Agriculural University - Laboratory of Ecology ( [http ...]
le Laboratoire d'écologie de la Faculté universitaire des Sciences Agronomiques de Gembloux ( [http ...]

Biological Control and Spatial Ecology Laboratory van de Université libre de Bruxelles (LUBIES - [http ...]
le laboratoire de lutte biologique et d'écologie spatiale de l'Université libre de Bruxelles (LUBIES - [http ...]

A national MRSA surveillance program was launched in collaboration with the federal Scientific Institute of Public Health and the reference laboratory for staphylococci (ULB-Erasme) to monitor the prevalence and incidence of MRSA in Belgian hospitals 22 and a decrease was observed after more than 80 % of the hospitals had adopted the national guidelines.
Un programme national de surveillance de MRSA a été lancé en collaboration avec l'Institut scientifique fédéral de Santé publique et le laboratoire de référence pour les staphylocoques (ULB-Erasme) afin de surveiller la prévalence et l’incidence de MRSA dans les hôpitaux belges 22 .

narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September
narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September

The external services of Unit II inspect manufacturers of medicines (in Belgium and non-EU countries), the wholesalers, the recognised laboratories, the companies recognised on the basis of the royal decree on raw materials used by the pharmacist, the manufacturers of “Active Pharmaceutical Ingredient” (API), blood establishments and cell and tissue banks.
The external services of Unit II inspect manufacturers of medicines (in Belgium and non-EU countries), the wholesalers, the recognised laboratories, the companies recognised on the basis of the royal decree on raw materials used by the pharmacist, the manufacturers of “Active Pharmaceutical Ingredient” (API), blood establishments and cell and tissue banks.

The latter has been designated as having expertise as an “Official Medicines Control Laboratory”, recognised by the FAMHP and the European Directorate for the Quality of Medicines (EDQM), for the monitoring of immunological products for veterinary use prior to marketing authorisation for the Belgian market.
The latter has been designated as having expertise as an “Official Medicines Control Laboratory”, recognised by the FAMHP and the European Directorate for the Quality of Medicines (EDQM), for the monitoring of immunological products for veterinary use prior to marketing authorisation for the Belgian market.

Confirmation of high-level resistance can be done at the Staphylococci reference laboratory by PCR for the mupA gene.
La confirmation d’une résistance de niveau élevé peut être effectuée au laboratoire de référence pour les staphylocoques par PCR pour le gène mupA.